Novolin-Pen® 4 should only be used in combination with compatible products
that allow the pen to function safely and effectively. Novolin-Pen® 4 is designed
to be used with Penfill® 3 mL insulin cartridges (referred to in this manual as
Penfill® cartridges) and NovoFine® disposable needles. Novolin-Pen®, Penfill®,
NovoFine® and Sare trademarks owned by Novo Nordisk A/S and used by
Novo Nordisk Canada Inc., under licence.
The CE-mark on a medical device indicates that the product conforms with the
provisions in the EC Directive for Medical Devices 93/42/EEC. Novolin-Pen® 4 fulfils
the specification limits for dose accuracy according to ISO 11608-1 Pen-Injectors
for Medical use, Part 1: Requirements and test methods.
Read this important information before you start using your Novolin-Pen® 4
$Novolin-Pen® 4 is not recommended for the blind or visually impaired,
without the assistance of a sighted individual trained to use the device.
$If you are treated with more than one type of insulin in cartridges, you
must use a different device for each type of insulin.
$In case your Novolin-Pen® 4 is lost or damaged, always carry a spare syringe
and extra insulin of the same type(s) you use.
$To minimize the risk of transmission of infectious diseases, your
Novolin-Pen® 4, your Penfill® cartridges and your NovoFine® disposable
needles should be used only by you.
$Keep your Novolin-Pen® 4, Penfill® cartridges and NovoFine® needles out of
reach of others, especially children.
8-4253-32-001-2_v1-9.qxp 8/9/2006 1:08 PM Page indv2
